Lipophilic Surfactant Research Articles

Reduction of Gastric Ulcerogenicity During Multiple Administration of Diclofenac Sodium by a Novel Solid-in-Oil Suspension

This article reports a significant reduction of gastric ulcerogenicity by complex formation of a nonsteroidal anti-inflammatory drug with surfactants. Diclofenac sodium (DFNa) was suspended in medium chain triglyceride (MCT) by forming a complex with an edible lipophilic surfactant. Two types of suspensions, prepared through a membrane emulsification with different pore sizes, were evaluated according to the degree of gastric damage following multiple oral administration in rats. It was shown that gastric ulcerogenicity of DFNa was reduced by the surfactant–drug complexes, at doses up to 12 mg/kg, whereas severe gastric damage was observed upon oral administration of the aqueous solution at doses of 6 mg/kg. Comparable blood levels of DFNa were observed after administration of solution and suspension formulations.

Influence of Surfactant on the Thermal Behavior of Marigold Oil Emulsions with Liquid Crystal Phases

ABSTRACTVegetable oils have been largely consumed owing to the interest of pharmaceutical and cosmetic industries in using natural raw materials. The production of stable emulsions with vegetable oils challenges formulators due to its variability in composition and fatty acids constitution within batches produced. In the present work, it was studied that the influence of the size of carbon chain and the number of ethylene oxide moieties of the surfactant on the thermal behavior of eight emulsions prepared with marigold oil stabilized by liquid crystal phases. Differential scanning calorimetry (DSC) was used to determine the thermal behavior of the emulsions. The ratio of bound water was calculated, being between 29.0 and 42.0%, confirming the extension of the liquid-crystalline net in the external phase. Changing the lipophilic surfactant from Ceteth-2 to Steareth-2, there was an increase in the temperature of phase transition of the liquid crystal influencing the system stability. Calorimetric study is very useful in understanding the performance of liquid crystals with the increase of temperature and to estimate emulsions stability.

Chiral imidazole metalloenzyme models: Synthesis and enantioselective hydrolysis for α-amino acid esters

Chiral imidazole hydrolytic metalloenzyme models with characteristics of chiral centers directly link to imidazole N-atoms and varieties in both alkyl chain length and number of alkyl chains, have been synthesised and investigated for enantioselective hydrolysis of Boc-α-amino acid esters. The result indicates that both hydrolysis rates and enantioselectivities are increased with increases in the alkyl chain length and the number of the alkyl chains in the lipophilic chiral imidazole-type surfactants in many cases. The lipophilic chiral imidazole 4d (( S)-1-hexadecoxy-2-(1-imidazolyl)-propane), which has one long alkyl chain, shows higher hydrolysis rate and enantioselectivity ( k D = 132.5 × 10 −5, k D/ k L = 5.38), 5d (( S)-1,5-dihexadecoxy-2-(1-imidazolyl)-pentane), which has two long alkyl chains, shows the highest hydrolysis rate and enantioselectivity ( k D = 201.5 × 10 −5, k D/ k L = 11.72). Additionally, the effects of the metals, the additives, the solvents and the substrates on the hydrolysis rates and enantioselectivities are examined.

Stability Studies on Colloidal Suspensions of Polyurethane Nanocapsules

Generally nanocapsules suspensions are a colloidal system in a metastable state, there is aggregation due to attraction and repulsion forces between particles. The objective of this work was to bring the role of the polymeric membrane in the protection of the active drug against damaging caused by external agents and to select the monomer which leads to obtain stable formulation with the highest possible payload of the active drug. The stability testing involving visual aspect, particle size measurement, transmission electron microscopy (TEM) examination, and drug loss was conduced after 6 months of storage at different temperatures (4, 25, and 45 degrees C). The colloidal suspensions of nanocapsules were obtained using the combined interfacial polycondensation and spontaneous emulsification, the technique was used to encapsulate alpha-tocopherol using polyurethanes polymers. It is a one step procedure: An organic phase composed of a water miscible solvent (acetone), lipophilic monomer (Isophorone diisocyanate IPDI), oil, and a lipophilic surfactant, is injected in an aqueous phase containing hydrophilic monomer (diol with various molecular weight: 1,2-ethanediol (ED), 1,4-butanediol (BD), and 1,6-hexanediol (HD)) and hydrophilic emulsifying agent. The water miscible solvent diffuses to the aqueous phase, the oil precipitates as nano-droplets, and the two monomers react at the interface, forming a membrane around the nanoemulsion leading to nanocapsules. A good physical stability of suspensions corresponds to absence of symptoms such as sedimentation or agglomeration, significant size change and alpha-tocopherol degradation due to external agents such as oxygen, temperature, and ultraviolet (UV) irradiation. The size of nanocapsules before storage was about 232 +/- 3, 258 +/- 29, and 312 +/- 4 nm for ED, BD, and HD, respectively. After 6 months of storage, polyurethanes nanocapsules possess good stability against aggregation at 4 and 25 degrees C. Comparing results obtained using different monomers, it reveals that the polyurethane based on HD offers good protection of alpha-tocopherol against damaging caused by the temperature and UV irradiation.

Dynamic interfacial tension behavior of the novel surfactant solutions and Daqing crude oil

The added surfactant, ionized acid and unionized acid adsorbed simultaneously onto the interface, resulting in the low DIT. Introducing sodium chloride has an obvious effect on DIT behavior of crude oil and surfactant flooding systems through affecting surface-active species’ absorption behavior onto interface and distribution between oil and water. With the increase of salinity, the required optimum surfactant concentrations increase. There exist obviously both synergism and antagonism between the added surfactant and inorganic salt (also between surfactant and alkaline) in lowing DIT. Towards the stronger lipophilic surfactant, antagonism occupies dominant, but synergism is dominant status if lipophilicity is weak. DIT curves between alkyl methylnaphthalene sulfonate surfactant solutions and Daqing crude oil take on “V-shape”. Through changing the parameters flooding systems like surfactant concentration, alkalinity and salinity, the shape of “V” curves may be changed, even DIT min. Therefore, varying parameters of flooding systems can satisfy the demand of DIT for crude oil in different oil field. For Daqing crude oil, the developed surfactants, except for Hex-MNS, exhibit good DIT behaviors. Based on the previous result, the AMNS surfactants might be a good candidate for enhanced oil recovery in different oil fields.

Preparation of biodegradable polymeric hollow microspheres using O/O/W emulsion stabilized by Labrafil ®

Biodegradable hollow microspheres were prepared by double oil and water emulsion using a lipophilic surfactant, Labrafil ® M 1944 CS. Olive oil was emulsified in biodegradable polymer-dissolved dichloromethane mixed with Labrafil by vigorous sonication. This oil-in-oil emulsion was directly re-emulsified in 0.1% poly(vinyl alcohol) solution, subsequently solidified by evaporating dichloromethane. Olive oil and Labrafil were extracted from the microspheres by using hexane. After vigorous washing with n-hexane, the hollow microsphere was freeze-dried and examined under scanning electron microscopy, confirming the morphology of hollow microspheres with thin walls and huge blank cores inside. The concentration of poly( l-lactide) in dichloromethane affected the size of hollow microspheres while the volume of olive oil or dichloromethane did not. This hollow microsphere is expected to be employed as an imaging contrast agent and a novel drug delivery vehicle.

Enhanced triolein removal using microemulsions formulated with mixed surfactants

AbstractIn previous work, a microemulsion‐based formulation approach yielded excellent laundry detergency with hydrophobic oily soils hexadecane and motor oil. In this work, the same approach is used in detergency of triolein, which is a model triglyceride, some of the most difficult oils to be removed from fabric. The linker concept was applied in formulation of the microemulsion system. Three different surfactants were used: (i) dihexyl sulfosuccinate, an ionic surfactant with a moderate hydrophile‐lipophile balance (HLB); (ii) secondary alcohol ethoxylate, a lipophilic nonionic surfactant with a very low HLB; and (iii) alkyl diphenyl oxide disulfonate (ADPODS), a hydrophilic anionic surfactant with a very high HLB. The phase behavior and interfacial tension (IFT) of the surfactant systems were determined with different concentrations of ADPODS. The results indicate that as the HLB of the system increases, a higher salinity is required to shift the phase transition from Winsor Type I to Type III to Type II. The three formulations at different salinities were used in detergency experiments to remove triolein from polyester/cotton sample fabric. The results showed that there were two peaks of maximum detergency in the range of salinity from 0.1% to 10% NaCl. The higher the hydrophilicity of the system, the higher the salinity required for maximum detergency. The results of the dynamic IFT and the detergency performance from two rinsing methods lead to the hypothesis that one of these maxima in detergency results from a spreading or wetting effect. The other maximum in detergency is believed to be related to ultralow IFT associated with oil/water middle‐phase microemulsion formation. Triolein removal exceeding 80% was attained, validating the microemulsion approach to detergency.

Mechanism of oil-in-water emulsification using a water-soluble amphiphilic polymer and lipophilic surfactant

A new O/W (oil-in-water) emulsification system was developed using the amphiphilic polymer HHM-HEC (hydrophobically–hydrophilically modified hydroxyethylcellulose) and a lipophilic surfactant. HHM-HEC was used as a thickener and polymeric surfactant, and the addition of small quantities of various types of nonionic lipophilic surfactant (hydrophilic–lipophilic balance <5) decreased the droplet size of several types of oil due to a lowering of the tension at the water/oil interface. The oil droplets were held by the strong network structure of the aqueous HHM-HEC solution, preserving the O/W phase without inversion. These stable O/W emulsions were prepared without the addition of hydrophilic surfactants and thus show improved water repellency.

Oral delivery of diclofenac sodium using a novel solid-in-oil suspension

The present work reports on a new pharmaceutical formulation for oral delivery of diclofenac sodium (DFNa), a non-steroidal anti-inflammatory drug (NSAID). Although DFNa itself is water-soluble at neutral pH, it was readily suspended in soybean oil via complex formation with an edible lipophilic surfactant and a matrix protein. The resulting solid-in-oil (S/O) suspension containing stably encapsulated DFNa in an oil phase markedly reduced the risks for gastrointestinal ulcers upon oral administration even at the LD 50 level in rats (ca. 50 mg/kg DFNa). In addition, plasma concentration of DFNa upon administration of an S/O suspension was comparable with that of the aqueous counterpart at the same DFNa dose. These results indicate the potential use of S/O suspensions as novel oil-based pharmaceutical formulations for oral delivery of water-soluble drugs without causing severe mucitis.

Diffusion behavior of pharmaceutical O/W microemulsions studied by dynamic light scattering

Dynamic light scattering experiments have been performed at various concentrations, of pharmaceutical oil-in-water microemulsions consisting of Eutanol G as oil, a blend of a high (Tagat O2) and a low (Poloxamer 331) hydrophilic–lipophilic balance surfactant, and a hydrophilic phase (propylene glycol/water). We probe the dynamics of these microemulsions by dynamic light scattering. In the measured concentration range, two modes of relaxation were observed. The faster decaying mode is ascribed classically to the collective diffusion D c (total droplet number density fluctuation). We show that the slow mode is also diffusive and suggest that its possible origin is the relaxation of polydispersity fluctuations. The diffusion coefficient associated with this mode is then the self-diffusion D s of the droplets. It was found that D c and D s had opposite volume fractions of oil plus surfactants (ϕ) dependence and a common limiting value D 0 for ϕ=0. Average hydrodynamic radius (R h=10.5 nm) of droplets was calculated from D 0. R h is supposed to compose the inner core, a surfactant film including possible solvent molecules, which migrate with the droplet. The concentration dependence of diffusion coefficients reflects the effect of hard sphere and the supplementary repulsive interactions which arises due to loss of entropy, when absorbed chains of surfactant intermingle on the close approach of the two droplets. This mechanism could also explain the observed stability of our systems. The estimated extent of polydispersity is 0.22 from the amplitude of slower decaying mode. The polydispersity in microemulsion systems is dynamic in origin. Results indicate that the time scale for local polydispersity fluctuations is at least three orders of magnitude longer than the estimated time between droplet collisions.

The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds

The design of the novel O/W microemulsion formulation, which enhances the oral bioavailability by raising the solubility of poorly water soluble compounds was examined. Using medium chain fatty acid triglyceride (MCT), diglyceryl monooleate (DGMO-C), polyoxyethylene hydrogenated castor oil 40 (HCO-40), ethanol and PBS (pH 6.8) as an oil phase, a lipophilic surfactant, a hydrophilic surfactant, a solubilizer and an aqueous phase, at the mixture ratio of 5%/1%/9%/5%/80% (w/w), respectively, the O/W microemulsion with an average particle diameter of 20 nm or less was prepared. Moreover, for nine kinds of poorly water soluble compounds, such as Ibuprofen, Ketoprofen, Tamoxifen, Testosterone, Tolbutamide and other new compounds, the solubility to water was increased from 60 to 20,000 times by this O/W microemulsion formulation. The AUCs in plasma concentration of Ibuprofen and a new compound, ER-1039, following single oral administration of these compounds as the O/W microemulsion to fasted rats were equivalent to that of solution administration or increased by nine and two times that of suspension administration, respectively. Accordingly, this novel O/W microemulsion is a useful formulation, which enhances the oral bioavailability by raising the solubility of poorly water soluble compounds.

Increasing and Decreasing pH to Enhance the Biological Activity of Nicosulfuron

Increasing the pH of the spray water to solubilize the weak acid herbicide nicosulfuron and then decreasing pH below its pKaso that it converts into a neutral form enhances biological activity under some conditions. The water-dispersible granule formulation of nicosulfuron starts as dispersed particles. Adding 1% wt/wt K3PO4solubilizes nicosulfuron and increases its activity compared to its dispersion without base. The type of buffer and the surfactant HLB or hydrophilic lipophilic balance, a measure of the molecular balance of the hydrophilic and lipophilic groups, altered the activity of nicosulfuron. Adding 1% wt/wt K3PO4increases the pH, and the optimum HLB ranged from 13 to 17 on large crabgrass. Adding 1% wt/wt H3PO4reduces the pH and lowers the optimum HLB range from 10 to 14 on large crabgrass. Adding the acidic buffer converts the solubilized nicosulfuron into its neutral form and increases activity under some surfactant conditions. Thus, neutral nicosulfuron is more active with lipophilic surfactants, while ionic nicosulfuron is more active with hydrophilic surfactants. When tested on other species, low HLB surfactants are the most active at low pH. These results support the concept that the physicochemical properties of the herbicide, adjuvants, and weed species should be matched for optimum activity.

Attainment of Emulsions with Liquid Crystal from Marigold Oil Using the Required HLB Method

Development of new formulations for topical use and cosmetic and pharmaceutical delivery agents has increased the complexity of emulsified systems. Liquid crystals, known since the nineteenth century are the third phase of an emulsion, being responsible for increasing its stability and the solubility of substances poorly soluble in water, or the oily phase, modulating the release of drugs imprisoned in its structure and promoting hydration of the skin surface. In the present work we developed oil/water emulsions, making use of Marigold oil (Calendula officinalis L) and ethoxylated fat alcohols as surfactant. The required HLB value for marigold oil was determined to be 6.0. The surfactants were associated in lipophilic/hydrophilic pairs. The lipophilic surfactants were Ceteth‐2 and Steareth‐2 and the hydrophilic surfactants were Steareth‐20, Ceteareth‐20, Ceteareth‐5, and Ceteth‐10. To identify the liquid crystalline phases, the emulsions were analyzed by polarized light microscopy. The physical stability was evaluated by rheology and zeta potential analysis. All emulsions presented lamellar liquid crystal structures. Results showed that this type of surfactant is able to produce liquid crystal in the system, with slight difference in appearance, influencing the physical stability, according to the methods applied.

Design of a phytosphingosine-containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of ceramides

Positively charged oil/water (o/w) nanoemulsions (PN) are effective vehicles to change the permeability of the skin. This study focused on the preparation and characterisation of phytosphingosine (PS) containing PN (PPN) which serve as colloidal carriers for the dermal application of ceramide IIIB (CIIIB) and the stratum corneum (SC) lipids (PPNSC) such as ceramide III (CIII), cholesterol, and palmitic acid. The investigations were conducted using appropriate emulsification and homogenisation processing conditions to optimise PPNSC with regard to droplet size, physical stability, and solubility of PS, CIII and CIIIB. A decrease in droplet size was observed through eight homogenisation cycles at a pressure of 500 bar and a temperature of 50 °C. Above these optimal values, an increase in droplet size was observed. PS and ceramides have low solubilities in oil and water. When Lipoid E-80 ® (LE80) was added to the oil phase, the solubility of PS and ceramides increased, indicating some interactions shown by DSC measurements. SC lipids and CIIIB could be successfully incorporated in PPN without producing any physical instability. The high stability of PPNSC is probably due to the presence of a hydrophilic (Tween 80) and a lipophilic surfactant (LE80), supported by the lipophilic cosurfactant PS, at the o/w interface. It was shown that PS was responsible for the positive charge and thus supported the high physical stability of PPNSC. This optimised emulsion was selected for further skin absorption evaluation.

Effect of surfactant on the characteristics of biodegradable microcapsules

The objective of this project was to evaluate the effect of several lipophilic surfactants on the characteristics of PLGA microcapsules. BSA was used as a model peptide. Seven different lipophilic surfactants were used and each of the surfactants was used at three different concentrations, 0.1, 0.5 and 1% (w/w), respectively. The microcapsules were prepared using the double emulsion solvent evaporation technique. The microcapsules were all spherical in shape with a smooth surface. The median size of the microcapsules varied between 4 and 49 μm. The zeta potential of the microcapsules varied between −26 and −43 mV. The efficiency of encapsulation varied between 8 and 45%. Efficiency of encapsulation appears to be dependant on both the type and concentration of the surfactant. Cumulative percent of BSA released up to 35 days varied from 18 to 78%. In conclusion, the physical characteristics of the microcapsules do not appear to be greatly affected by the type of surfactant. All of the samples appear to show polydispersity in their particle sizes. Particle charge depended on both the type and concentration of the surfactant. The overall dissolution of these microcapsules was very slow.

The Novel Formulation Design of Self-emulsifying Drug Delivery Systems (SEDDS) Type O/W Microemulsion II: Stable Gastrointestinal Absorption of a Poorly Water Soluble New Compound, ER-1258 in Bile-fistula Rats

The stabilization effect of the novel self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion on the gastrointestinal absorption of a poorly water soluble new compound, ER-1258 was examined by bile-fistula model rats. In the components of this formulation, medium chain fatty acid triglyceride (MCT), diglyceryl monooleate (DGMO-C), polyoxyethylene hydrogenated castor oil 40 (HCO-40) and ethanol were used as an oil, a lipophilic surfactant, a hydrophilic surfactant and a solubilizer at the mixture ratio of 25/5/45/25 w/w%, respectively. The ratios of AUC in the non-treated rats to that in the bile-fistula rats were 5.1, 12.1 and 3.0 for the suspension, the oily solution and the SEDDS type O/W microemulsion, respectively. The risk from which the difference between individuals of the compound absorption amounts resulting from the flow of the bile secretion serves as the maximum was high in order of oily solution>suspension>SEDDS type O/W microemulsion. Therefore, it was verified that the SEDDS type O/W microemulsion was able to reduce this risk, compared with the other formulations. When short chain fatty acid triglyceride (Triacetin) was used as an oil, the similar effect was demonstrated in the formulation composed of sorbitan sesquioleate (SO-15) as a lipophilic surfactant and polyoxyethylene hydrogenated castor oil 60 (HCO-60) or polyoxyethylene 20 sorbitan monooleate (TO-10M) as a hydrophilic surfactant.

The Novel Formulation Design of Self-emulsifying Drug Delivery Systems (SEDDS) Type O/W Microemulsion I: Enhancing Effects on Oral Bioavailability of Poorly Water Soluble Compounds in Rats and Beagle Dogs

We examined the design of the versatile novel self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion formulation which enhances the oral bioavailability by raising the solubility of poorly water soluble compounds. Namely, seven kinds of poorly water soluble compounds such as disopyramide, ibuprofen, ketoprofen, tolbutamide, and other new compounds, as the model compounds were used to compare the plasma concentration profile of the compound following single oral administration of each compound to rats and beagle dogs as a solution, an oily solution, a suspension (or a powder), an O/W microemulsion, and a SEDDS type O/W microemulsion. And the enhancing effect of the SEDDS type O/W microemulsion on the gastrointestinal absorption of these compounds was evaluated. In the components of the SEDDS type O/W microemulsion, medium chain fatty acid triglyceride (MCT), diglyceryl monooleate (DGMO-C), polyoxyethylene hydrogenated castor oil 40 (HCO-40), and ethanol were used as an oil, a lipophilic surfactant, a hydrophilic surfactant, and a solubilizer, at the mixture ratio of 25/5/45/25 (w/w%), respectively. Thereby, to six kinds of the model compounds except disopyramide, the solubility was from 340 to 98,000 times that in water, and the AUCs in plasma concentration of the compound were equivalent to that of solution or O/W microemulsion administration, or was increased by 1.5 to 78 times that of suspension administration. Accordingly, this novel SEDDS type O/W microemulsion is the versatile, useful formulation which enhances the oral bioavailability by raising the solubility of poorly water soluble compounds.

Polysaccharide gel with multiple emulsion

The aim of the present work was to investigate the possibility of using a semicrystalline oil phase in W/O/W to modify the release of encapsulated hydrophilic compounds from polysaccharide gels with embedded multiple emulsions. l-Tryptophan was enclosed within the W 1-phase of an W 1/O/W 2-emulsion, which itself was homogeneously distributed in a Ca 2+-alginate gel with maltodextrin (D.E. 6.5) as a bulking agent. Various lipid phases, including MCT-oil and different vegetable fats, were investigated for their ability to act as a hydrophobic barrier in the oil phase. In addition, the content of the lipophilic surfactant PGPR in the oil phase was varied. A marked increase in encapsulation efficacy was observed by lowering the storage temperature of the emulsion gels from 23 to 7 °C. Also, among the various lipids used for sample preparation, differences in release rate were found. Increasing the fat content in the oil phase resulted in decreased marker diffusion. The lowest release rate was achieved by using the fat with the highest melting point and by increasing the fat content to 100% of the oil phase. Lowering the content of PGPR in the MCT-oil phase (without fat) had no effect on the release of tryptophan.

Effects of added nonionic surfactant and inorganic salt on the rheology of sugar surfactant and CTAB aqueous solutions

The effect of adding tri(oxyethylene) dodecyl ether (C 12EO 3) on the phase and rheological behavior of sucrose hexadecanoate and CTAB aqueous solutions in the presence of added salt (NaBr) was investigated. Viscoelastic solutions are formed in CTAB and C 16SE systems upon addition of lipophilic nonionic surfactant C 12EO 3. The zero-shear viscosity shows a maximum at a certain mixing fraction of C 12EO 3, except in the case of the aqueous CTAB/C 12EO 3 system in the absence of salt. The rheological properties are strongly affected by the addition of salt to the CTAB systems but they remain unaltered in the case of C 16SE systems. In ionic systems, the mixing fraction of C 12EO 3 for the maximum viscosity depends on salt concentration.

Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation

Nano-emulsions consist of fine oil-in-water dispersions, having droplets covering the size range of 100–600 nm. In the present work, nano-emulsions were prepared using the spontaneous emulsification mechanism which occurs when an organic phase and an aqueous phase are mixed. The organic phase is an homogeneous solution of oil, lipophilic surfactant and water–miscible solvent, the aqueous phase consists on hydrophilic surfactant and water. An experimental study of nano-emulsion process optimisation based on the required size distribution was performed in relation with the type of oil, surfactant and the water–miscible solvent. The results showed that the composition of the initial organic phase was of great importance for the spontaneous emulsification process, and so, for the physico-chemical properties of the obtained emulsions. First, oil viscosity and HLB surfactants were changed, α-tocopherol, the most viscous oil, gave the smallest droplets size (171 ± 2 nm), HLB required for the resulting oil-in-water emulsion was superior to 8. Second, the effect of water–solvent miscibility on the emulsification process was studied by decreasing acetone proportion in the organic phase. The solvent–acetone proportion leading to a fine nano-emulsion was fixed at 15/85% (v/v) with EtAc–acetone and 30/70% (v/v) with MEK–acetone mixture. To strength the choice of solvents, physical characteristics were compared, in particular, the auto-inflammation temperature and the flash point. This phase of emulsion optimisation represents an important step in the process of polymeric nanocapsules preparation using nanoprecipitation or interfacial polycondensation combined with spontaneous emulsification technique.